Author: Joe Kays
FDA approves Banyan Biomarkers’ traumatic brain injury blood test
February 15, 2018In February, the U.S. Food and Drug Administration cleared UF spinoff Banyan Biomarkers to begin marketing the first blood test to evaluate mild traumatic brain injury (mTBI), or concussion, in […]